Portfolio company
DNA Script
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
This company develops benchtop enzymatic DNA synthesis instruments for life science researchers and laboratories to produce synthetic nucleic acids on demand.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Molecular Assemblies
This company develops enzymatic DNA synthesis technology to provide long, high-quality oligonucleotides for researchers in synthetic biology, therapeutics, diagnostics and data storage.
Evonetix
The company develops a desktop DNA synthesis platform for researchers in synthetic biology and drug development to produce high-fidelity gene sequences.
Ansa Biotechnologies
This company manufactures synthetic DNA using enzymatic synthesis technology for researchers in biological engineering, therapeutics, diagnostics and agriculture.
Ansa Biotech
The company develops enzymatic DNA synthesis technology to provide complex genetic sequences for biopharmaceutical researchers and life science laboratories.
Telesis Bio
Telesis Bio develops automated synthetic biology workstations and reagents for researchers to perform rapid, on-site DNA and mRNA synthesis.
Nunabio
This company develops enzymatic technology for the synthesis of complex DNA sequences for customers in the biotechnology, pharmaceutical and materials science sectors.
Dinya
Dinya develops enzymatic DNA synthesis technology to provide rapid, custom gene-length DNA sequences for healthcare researchers and pharmaceutical manufacturers.
EnPlusOne
This company develops enzymatic RNA synthesis technology for biotechnology firms and pharmaceutical manufacturers to produce oligonucleotides for therapeutic applications.